T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRGI
476
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $168M | 0.04% |
2,766,416
+424,816
| +18% | +$23.4M |
|
|
WUBA
477
DELISTED
58.com Inc
WUBA
| $168M | 0.04% |
4,036,760
+480,322
| +14% | +$19.8M |
|
478
Broadcom
AVGO
$1.98T
| $167M | 0.04% |
16,640,400
-1,145,500
| -6% | -$10.2M |
|
479
Enviri
NVRI
$583M
| $167M | 0.04% |
8,852,868
-962,261
| -10% | -$18.7M |
|
|
DNKN
480
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $167M | 0.04% |
3,904,200
+194,000
| +5% | +$8.88M |
|
481
Ionis Pharmaceuticals
IONS
$9.39B
| $165M | 0.04% |
2,678,378
-76,372
| -3% | -$3.77M |
|
|
CORE
482
DELISTED
Core Mark Holding Co., Inc.
CORE
| $165M | 0.04% |
5,328,200
-218,520
| -4% | -$6.34M |
|
|
CKH
483
DELISTED
Seacor Holdings Inc.
CKH
| $164M | 0.03% |
2,300,492
-159,580
| -6% | -$11.6M |
|
484
Cognizant
CTSH
$26.2B
| $161M | 0.03% |
3,066,445
-1,792,340
| -37% | -$89.5M |
|
485
Aramark
ARMK
$15.9B
| $160M | 0.03% |
7,128,872
+3,158,908
| +80% | +$64.6M |
|
486
Archrock
AROC
$5.84B
| $160M | 0.03% |
4,918,122
-3,235,042
| -40% | -$116M |
|
|
BHI
487
DELISTED
Baker Hughes
BHI
| $160M | 0.03% |
2,852,919
+439,857
| +18% | +$24.8M |
|
488
Packaging Corp of America
PKG
$22.8B
| $157M | 0.03% |
2,012,044
-270,143
| -12% | -$19.4M |
|
489
Louisiana-Pacific
LPX
$5.15B
| $156M | 0.03% |
9,423,060
+1,074,940
| +13% | +$16.1M |
|
490
Pebblebrook Hotel Trust
PEB
$2.04B
| $156M | 0.03% |
3,413,556
+40,290
| +1% | +$1.69M |
|
491
Kemper
KMPR
$1.56B
| $155M | 0.03% |
4,283,724
-58,551
| -1% | -$2.06M |
|
|
TIF
492
DELISTED
Tiffany & Co.
TIF
| $152M | 0.03% |
1,426,256
+228,163
| +19% | +$22.8M |
|
|
EE
493
DELISTED
El Paso Electric Company
EE
| $152M | 0.03% |
3,788,500
+2,900
| +0.1% | +$110K |
|
494
A.O. Smith
AOS
$8.51B
| $152M | 0.03% |
5,371,500
-21,000
| -0.4% | -$548K |
|
495
M&T Bank
MTB
$36.6B
| $151M | 0.03% |
1,204,784
+420,810
| +54% | +$51.7M |
|
496
Aon
AON
$74.7B
| $151M | 0.03% |
1,592,862
+24,883
| +2% | +$2.23M |
|
497
Belden
BDC
$5.39B
| $150M | 0.03% |
1,906,463
-15,600
| -0.8% | -$1.11M |
|
|
EA
498
DELISTED
Electronic Arts
EA
| $149M | 0.03% |
3,174,602
+856,077
| +37% | +$35.3M |
|
499
CME Group
CME
$94.3B
| $149M | 0.03% |
1,682,835
+150,060
| +10% | +$12.7M |
|
500
TE Connectivity
TEL
$62B
| $149M | 0.03% |
2,354,114
-141,120
| -6% | -$8.49M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.